Skip to content

Can patients with fibromyalgia be improved by subcutaneous injections of sterile water in tenderpoints? A randomised, controlled, tripple masked clinical trial

Can patients with fibromyalgia be improved by subcutaneous injections of sterile water in tenderpoints? A randomised, controlled, tripple masked clinical trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-000654-67-SE
Enrollment
60
Registered
2005-02-17
Start date
2005-04-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

Trade Name: Sterile water Product Name: Sterile water Product Code: - Pharmaceutical Form: Injection* Pharmaceutical form of the placebo: Injection* Route of administration of the placebo: Subcutaneou

Sponsors

Uppsala University/Uppsala County Council
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Women, less than 65 years old, non-pregnant, non-brest feeding Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Symptoms or signs of rheumatoid arthritis, multiple sclerosis, malignancy, or other serious disease

Design outcomes

Primary

MeasureTime frame
Main Objective: To test the hypothesis that injections of sterile water in the tenderpoints relieves the pain symptoms during at least one year;Secondary Objective: The pain relief is caused by a "resetting" of the nosoceptors, in turn caused by changes in the release of neuropeptides;Primary end point(s): Number of tenderpoints, arm abduction test, chair raising test, and a set of quality of life measures

Countries

Sweden

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026